Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics (Q42996149)
scientific article published in November 2005
Language:
Current Data About Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics
(P31) (Q13442814)
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P50) (Q87417017)
(P1545) 4
(P1932) Jean Molleston
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(Q116804726)
(P1545) 2
(P1932) Deirdre A Kelly
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P304) 1010-1018
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P407) (Q1860)

(P433) 5
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P478) 42
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P577) Tuesday, November 1, 2005
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P921) (Q421862)
(P887)

(Q154869)
(P887)

(Q55779873)
(P887)

(Q62019625)
(P887)

(Q323936)
(P887)

(P1433) (Q15724398)
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P1476) "Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics" (language: en)
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P2093) Regino P González-Peralta
(P1545) 1
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Barbara Haber
(P1545) 3
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Karen F Murray
(P1545) 5
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Maureen M Jonas
(P1545) 6
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Mark Shelton
(P1545) 7
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Giorgina Mieli-Vergani
(P1545) 8
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Yoav Lurie
(P1545) 9
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Steven Martin
(P1545) 10
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Thomas Lang
(P1545) 11
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Andrew Baczkowski
(P1545) 12
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Michael Geffner
(P1545) 13
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Samir Gupta
(P1545) 14
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

Mark Laughlin
(P1545) 15
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

International Pediatric Hepatitis C Therapy Group
(P1545) 16
(P248)
(P698) 16250032
(P813) Sunday, November 12, 2017

(P2860) (Q77485792)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q77729258)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q35960898)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q34468526)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q27861083)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q45752944)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q42981961)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q42985824)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q29620971)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q42988723)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q42990465)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q29620070)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q43493594)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q35802787)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q50587051)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q39548769)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q50585007)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q40572302)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q43000743)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q50922048)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

(Q55033918)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FHEP.20884
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published in November 2005

External Links
(P356) 10.1002/HEP.20884
(P698) 16250032
(P5875) 7516668
(P8608) release_s6tp7kyi6jedtcha4gul2bcaeu